Assessment of montelukast, doxofylline, and tiotropium with budesonide for the treatment of asthma: Which is the best among the second-line treatment? A randomized trial

Clinical Therapeutics

Volumn 37, Issue 2, 2015, Pages 418-426

  Rajanandh, Muhasaparur Ganesan ^a   Nageswari, Arcot D ^b   Ilango, Kaliappan ^b  

^a SRI RAMACHANDRA UNIVERSITY   (India)

^b SRM INSTITUTE OF SCIENCE AND TECHNOLOGY   (India)

Author keywords

budesonide; doxofylline; formoterol; montelukast; tiotropium

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; CORTICOSTEROID; DOXOFYLLINE; FORMOTEROL; MONTELUKAST; MUSCARINIC RECEPTOR BLOCKING AGENT; TIOTROPIUM BROMIDE; ACETIC ACID DERIVATIVE; BRONCHODILATING AGENT; QUINOLINE DERIVATIVE; THEOPHYLLINE;

ADULT; ARTICLE; ASTHMA; CHEMOTHERAPY; CONSTIPATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FATIGUE; FORCED EXPIRATORY VOLUME; HEADACHE; HEART PALPITATION; HUMAN; INSOMNIA; LOW DRUG DOSE; LUNG FUNCTION; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MICTURITION DISORDER; MULTIPLE LINEAR REGRESSION ANALYSIS; NAUSEA; OUTCOMES RESEARCH; PILOT STUDY; QUALITY OF LIFE; QUESTIONNAIRE; SAINT GEORGE RESPIRATORY QUESTIONNAIRE; SCORING SYSTEM; SECOND LINE TREATMENT; SMOKING; STOMACH DISEASE; STOMACH PAIN; SYMPTOM; TACHYCARDIA; THRUSH; TREATMENT OUTCOME; VOMITING; XEROSTOMIA; ADOLESCENT; ANALOGS AND DERIVATIVES; CONTROLLED STUDY; DRUG COMBINATION; DRUG EFFECTS; FEMALE; LUNG FUNCTION TEST; PHYSIOLOGY; PROCEDURES; RANDOMIZED CONTROLLED TRIAL;

ACETATES; ADOLESCENT; ADULT; ASTHMA; BRONCHODILATOR AGENTS; BUDESONIDE; DRUG THERAPY, COMBINATION; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; QUINOLINES; RESPIRATORY FUNCTION TESTS; THEOPHYLLINE; TIOTROPIUM BROMIDE;

EID: 84923654867     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2014.12.008     Document Type: Article

References (23)

1. M.G. Rajanandh, A.D. Nageswari, and K. Ilango Pulmonary function assessment in mild to moderate persistent asthma patients receiving montelukast, doxofylline and tiotropium with budesonide: a randomized controlled study Clin Ther 36 2014 526 533
2. S.R. Wilson, C.S. Rand, and M.D. Cabana Asthma outcomes: quality of life J Allergy Clin Immunol 129 2012 S88 S123
3. M. Molimard, J. Bourcereau, and V.L. Gros Comparison between formoterol 12 mg b.i.d. and on demand salbutamol in moderate persistent asthma Respir Med 95 2001 64 70
4. M.L. Levy, M. Thomas, and I. Small Summary of the 2008 BTS/SIGN British Guideline on the management of asthma Prim Care Respir J 18 2009 S1 S16
5. M.G. Rajanandh, A.D. Nageswari, and K. Ilango Influence of demographic status on pulmonary function, quality of life and symptom scores in patients with mild to moderate persistent asthma J Exp Clin Med 6 2014 102 104
6. P. Calverley, R. Paulwels, and J. Vestbo Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomized controlled trial Lancet 361 2003 449 456
7. M.G. Rajanandh, A.D. Nageswari, and K. Ilango Development and validation of knowledge, attitude, practice questionnaire for asthma and assessment of impact of patient education on asthma patients Int J Pharm Pharm Sci 6 2014 309 311
8. M.G. Rajanandh, A.D. Nageswari, P.P. Irshad, and C. Ramasamy Does dose reduction of an inhaled corticosteroid with the addition of leukotriene antagonist is clinical significance in asthma patients? a randomized clinical trial World Appl Sci J 24 2013 276 281
9. D.S. Robinson The role of the mast cell in asthma: induction of airway hyper responsiveness by interaction with smooth muscle? J Allergy Clin Immunol 114 2004 58 65
10. M.G. Rajanandh, A.D. Nageswari, and K. Ilango Effect of two controller medications with inhaled corticosteroid in mild to moderate persistent asthma patients J Med Sci 14 2014 81 86
11. P.K. Keith, C. Koch, and M. Djandji Montelukast as add-on therapy with inhaled corticosteroids or inhaled corticosteroids and long-acting beta-2-agonists in the management of patients diagnosed with asthma and concurrent allergic rhinitis (The RADAR Trial) Can Respir J 16 2009 17 24
12. J.C. Virchow, A. Mehta, Li Ljungblad, and H. Mitfessel Add-on montelukast in inadequately controlled asthma patients in a 6-month open-label study: the MONtelukast In Chronic Asthma (MONICA) study Respir Med 104 2010 644 651
13. S. Joos, A. Miksch, and J. Szemcsenyi Montelukast as add-on therapy to inhaled corticosteroids in the treatment of mild to moderate asthma: a systematic review Thorax 63 2008 453 462
14. M.G. Rajanandh, A.D. Nageswari, and K. Ilango Assessment of various second-line medications in addition to inhaled corticosteroid in asthma patients: a randomized controlled trial Clin Exp Pharmacol Physiol 41 2014 509 513
15. O. Akbari, J.L. Faul, and E.G. Hoyte CD4+ invariant T-cell-receptor+ natural killer T cells in bronchial asthma N Engl J Med 354 2006 1117 1129
16. E. Befekadu, C. Onofrei, and G.L. Colice Tiotropium in asthma: a systematic review J Asthma Allergy 7 2014 11 21
17. T. Wang, G. Luo, and Y. Hu Comparative study on the efficacy of tiotropium bromide inhalation and oral doxofylline treatment of moderate to severe stable chronic obstructive pulmonary disease J Huazhong Univ Sci Technol Med Sci 31 2011 614 618
18. E.D. Bateman, H.A. Boushey, J. Bousquet GOAL Investigators Group Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study Am J Respir Crit Care Med 170 2004 836 844
19. J.V. Fahy Eosinophilic and neutrophilic inflammation in asthma: insights from clinical studies Proc Am Thorac Soc 6 2009 256 259
20. H. Iwamoto, A. Yokoyama, and N. Shiota Tiotropium bromide is effective for severe asthma with noneosinophilic phenotype Eur Respir J 31 2008 1379 1380
21. S.W. Um, C.G. Yoo, and Y.W. Kim The combination of tiotropium and budesonide in the treatment of chronic obstructive pulmonary disease J Korean Med Sci 22 2007 839 845
22. M.L. Moy, E. Israel, and S.T. Weiss Clinical predictors of health-related quality of life depend on asthma severity Am J Respir Crit Care Med 163 2001 924 929
23. S. Thomas, G.S. Parthasarathi, and P. Shilpa Quality of life assessment in asthmatic patients receiving fluticosone compared with equipotent doses of beclomethasone or budesonide Lung India 22 2005 86 91